CD8A and hepatocellular carcinoma: In other cancers, including melanoma [27], hepatocellular carcinoma [28,29] and breast cancer [30], increased frequencies of tetramer-reactive CD8+ cells have been reported, although none of these studies found as high frequencies of tetramer-reactive cells as found in our current study.